Related Experiment Video
Updated: Mar 14, 2026

11:56
Ex Vivo Infection of Murine Epidermis with Herpes Simplex Virus Type 1
Published on: August 24, 2015
11.7K
Echovirus 1 internalization negatively regulates epidermal growth factor receptor downregulation
Moona Huttunen1, Paula Turkki1, Anita Mäki1
1Department of Biological and Environmental Science/NanoScience Center, University of Jyväskylä, Jyväskylä, Finland.
Cellular Microbiology
|September 26, 2016
Summary
Echovirus 1 (EV1) infection inhibits epidermal growth factor receptor (EGFR) downregulation, promoting viral spread. This specific interference with EGFR trafficking benefits EV1 infection and enhances cell viability.
Area of Science:
- Cell Biology
- Virology
- Molecular Biology
Background:
- Echovirus 1 (EV1) utilizes a distinct internalization pathway separate from the epidermal growth factor receptor (EGFR) pathway.
- EV1 and EGFR pathways exhibit close proximity but different degradation kinetics.
Purpose of the Study:
- To investigate the interaction between EV1 and EGFR trafficking pathways.
- To determine if EV1 affects EGFR downregulation and cellular processes.
Main Methods:
- Live and confocal microscopy to track EV1 and EGFR vesicles.
- Analysis of EGFR levels and localization in infected cells.
- Assessment of EV1 infection and cell viability under different treatment conditions.
Main Results:
- EV1 inhibits EGFR downregulation, leading to EGFR accumulation in cytoplasmic endosomes.
- EV1 does not broadly disrupt cellular trafficking or transferrin recycling.
- EGFR pathway activation enhances EV1 infection and cell survival.
- EV1-induced EGFR phenotype may involve protein kinase C alpha activation.
Conclusions:
- EV1 specifically interferes with EGFR trafficking, hindering its downregulation.
- This specific interaction benefits EV1 infection by enhancing viral spread and cell viability.
More Related Videos
Related Concept Videos
Receptor Downregulation in MVBs
2.9K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.9K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.8K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
Mitogens and the Cell Cycle
8.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Clinical Applications of Epidermal Stem Cells
3.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K

